The 2023 International Conference on CRISPR Technologies will focus on the latest advances in the genome editing field, bringing together key stakeholders with aligned interests across the spheres of academia and industry. The program will feature talks across many facets of this field, including the optimization of safe and effective DNA, RNA, and epigenetic editing technologies; the continued discovery and optimization of naturally-occurring CRISPR and non-CRISPR enzymes; the development of precision technologies capable of generating nucleotide- or kilobase-scale edits; and overcoming barriers to realizing the full potential of each of these tools.

Session Topics
CRISPR Biology, Tools, and Applications
Structural Biology and Synthetic Biology
Genome Editing Technologies for Small Sequence Edits
Genome Editing Technologies for Large Sequence Edits
Epigenetic and RNA Editing
High-Throughput Functional Genomics
Therapeutic Considerations
Progress Towards the Clinic
Advances in Delivery

Conference Chairs
Andrew Anzalone, Prime Medicine
Benjamin Kleinstiver, Massachusetts General Hospital
Kristin Knouse, Massachusetts Institute of Technology

Organizing Committee

Britt Adamson, Princeton University
Mandana Arbab, Boston Children’s Hospital
Morgan Maeder, Chroma Medicine
Jeffrey Quinn, Beam Therapeutics
Matthew Stanton, Generation Bio
Jonathan Strecke, Broad Institute


Who Should Attend
-Scientists at all career stages
-Cell biologists in academia and industry at all levels
-Scientists in industry and academia
-Students and senior researchers
-Industry decision makers/ tech scouts looking to speed up research and foster new applications

Funding Opportunity is Available!